Register for our free email digests:
Latest From Agila Specialties Pvt. Ltd.
Strides Shasun’s founder Arun Kumar has said he will take a backseat strategic role as the Indian pharma firm moves into ‘Version 2’ of its avatar, and will let new leadership drive the company to the ‘next level’ after fourth-quarter earnings nearly tripled.
What began as an overseas recall of one lot made by a Pfizer subsidiary is expanding, threatening to besmirch Mylan’s once golden supply-chain quality record. The recall follows pricing controversy around the EpiPen product got the CEO hauled before Congress.
Pricing controversy around the product got the CEO hauled before Congress; now what began as an overseas recall of one lot made by a Pfizer subsidiary threatens to besmirch Mylan’s once golden supply chain quality record.
Mylan has handed pink slips to around 50 personnel at its Indian R&D unit as it pursues a global revamp aimed at streamlining operations and reining in costs following multiple acquisitions over the past few years.
- Medical Devices
- Therapeutic Areas
- Neurology, Nervous System
- Respiratory, Pulmonary
- Almirall Prodesfarma SA
- Laboratorios Almirall SA
- Western Europe
- Parent & Subsidiaries
- Almirall SA
- Senior Management
Eduardo Sanchiz Yrazu, CEO
Jorge Gallardo Ballart, Pres.
- Contact Info
Phone: (34) 93 291 30 00
General Mitre, 151
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.